Markets:

Overview

News

Currencies

International

Treasuries

MacroGenics, Inc. - Common Stock (NQ:MGNX)

1.800 -0.030 (-1.63%)

Streaming Delayed Price Updated: 10:22 AM EST, Jan 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MacroGenics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call

October 31, 2023

From MacroGenics, Inc.

Via GlobeNewswire

Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race

October 10, 2023

Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...

Via PressReach

MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program

September 05, 2023

From MacroGenics, Inc.

Via GlobeNewswire

Why Shares of MacroGenics Are Jumping Thursday ↗

August 10, 2023

The company announced second-quarter earnings.

Via The Motley Fool

MacroGenics to Participate in Upcoming Investor Conferences

August 31, 2023

From MacroGenics, Inc.

Via GlobeNewswire

3 Under-the-Radar Biotech Stocks to Buy in 2023 ↗

August 19, 2023

All three biotech companies focus on oncology therapies.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 10, 2023

Via Benzinga

Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss ↗

August 10, 2023

The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight increase from 3% to 3.2% last month, breaking a streak of 12 consecutive months of decline.

Via Benzinga

Topics ETFs Economy

MacroGenics (MGNX) Q1 2023 Earnings Call Transcript ↗

May 10, 2023

MGNX earnings call for the period ending March 31, 2023.

Via The Motley Fool

Recap: Macrogenics Q1 Earnings ↗

May 09, 2023

Via Benzinga

Earnings Outlook For Macrogenics ↗

May 08, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Macrogenics ↗

March 21, 2023

Via Benzinga

Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

August 10, 2023

Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.

Via Benzinga

Alibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On Thursday ↗

August 10, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 350 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Why MacroGenics Stock Tumbled Today ↗

March 17, 2023

The company had quite a comedown shortly after releasing its latest set of annual results.

Via The Motley Fool

MacroGenics (MGNX) Q2 2023 Earnings Call Transcript ↗

August 09, 2023

MGNX earnings call for the period ending June 30, 2023.

Via The Motley Fool

Topics Earnings

MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference Call

July 31, 2023

From MacroGenics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 05, 2023

Via Benzinga

MacroGenics Announces Date of First Quarter 2023 Financial Results Conference Call

May 04, 2023

From MacroGenics, Inc.

Via GlobeNewswire

Macrogenics's Return On Capital Employed Insights ↗

March 16, 2023

Via Benzinga

MacroGenics to Participate in Upcoming Investor Conferences

April 24, 2023

From MacroGenics, Inc.

Via GlobeNewswire

Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 10, 2023

Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 03, 2023

Via Benzinga

Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval ↗

March 23, 2023

Via Benzinga

MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)

March 22, 2023

From MacroGenics, Inc.

Via GlobeNewswire

Why MacroGenics Stock Inched Higher on Monday ↗

March 20, 2023

A pair of more-bullish analyst evaluations gave hope to investors.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023 ↗

March 17, 2023

Via Benzinga

Why Shares of MacroGenics Climbed Thursday ↗

March 16, 2023

The cancer-focused biotech delivered a strong earnings report.

Via The Motley Fool

Signet Jewelers, Designer Brands, Academy Sports and Outdoors And Other Big Stocks Moving Higher On Thursday ↗

March 16, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 250 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 16, 2023

Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.